Cellares
Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.
$257MSeries D
Role not disclosedDG
DC Global Ventures
Activity from announced rounds
Activity in this selectionOct 25, 2026 · North America · Jan 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $257M 1 disclosed · full round size, not this investor’s share